Xenon Pharmaceuticals Inc. (XENE) Gained 8.63% or 0.65 To Price $8.18 On Tuesday


Xenon Pharmaceuticals Inc. (XENE) gained 8.63% or 0.65 to $8.18. It is close to 167440 shares traded, which is 81.02% compare to the average total volume 206671. The market cap of XENE is $206.47 million. The year to date change is 21.36%. The 52 week price range is from $2.7 to $15.92. Price of XENE have changed 19.33% during last week. It have changed 3.01% over last month, -31.11% over last 3 months, -21.56% over last 6 months and 159.66% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for XENE is 8.14. It is -0.49% below current price. The stock is at support level of 50-day moving averages. The 200-day Moving Averages for XENE is 8.67. It is 5.99% above current price. The 52-week High is 15.92. It is 94.62% from the current price. The 52-week Low is 2.7. It is -66.99% from current price.

There are some statistics of XENE. It is has market cap $206.47 million. The share outstanding is 25.24 million. The average volume is 206671. The percent of top 15 Institution holding is 81.00%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of XENE is -44.34%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of XENE is -35.72%.


Tags:

Share this post